These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


288 related items for PubMed ID: 15934253

  • 21. Cyclosporine in veterinary dermatology.
    Palmeiro BS.
    Vet Clin North Am Small Anim Pract; 2013 Jan; 43(1):153-71. PubMed ID: 23182330
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of a new topical cyclosporine A formulation in the treatment of atopic dermatitis in dogs.
    Puigdemont A, Brazís P, Ordeix L, Dalmau A, Fuertes E, Olivar A, Pérez C, Ravera I.
    Vet J; 2013 Aug; 197(2):280-5. PubMed ID: 23562341
    [Abstract] [Full Text] [Related]

  • 23. A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis.
    Moyaert H, Van Brussel L, Borowski S, Escalada M, Mahabir SP, Walters RR, Stegemann MR.
    Vet Dermatol; 2017 Dec; 28(6):593-e145. PubMed ID: 28906040
    [Abstract] [Full Text] [Related]

  • 24. Ciclosporin therapy is associated with minimal changes in calcium metabolism in dogs with atopic dermatitis.
    Kovalik M, Mellanby RJ, Evans H, Berry J, van den Broek AH, Thoday KL.
    Vet Dermatol; 2012 Dec; 23(6):481-e91. PubMed ID: 23140314
    [Abstract] [Full Text] [Related]

  • 25. A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis.
    Cosgrove SB, Wren JA, Cleaver DM, Walsh KF, Follis SI, King VI, Tena JK, Stegemann MR.
    Vet Dermatol; 2013 Dec; 24(6):587-97, e141-2. PubMed ID: 24581322
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Cyclosporin A Treatment in Intrinsic Canine Atopic Dermatitis (Atopic-like Dermatitis): Open Trial Study.
    Fujimura M, Nakatsuji Y, Ishimaru H.
    Pol J Vet Sci; 2016 Sep 01; 19(3):567-572. PubMed ID: 27760033
    [Abstract] [Full Text] [Related]

  • 28. The influence of topical unsaturated fatty acids and essential oils on normal and atopic dogs.
    Tretter S, Mueller RS.
    J Am Anim Hosp Assoc; 2011 Sep 01; 47(4):236-40. PubMed ID: 21673338
    [Abstract] [Full Text] [Related]

  • 29. A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.
    Michels GM, Ramsey DS, Walsh KF, Martinon OM, Mahabir SP, Hoevers JD, Walters RR, Dunham SA.
    Vet Dermatol; 2016 Dec 01; 27(6):478-e129. PubMed ID: 27647569
    [Abstract] [Full Text] [Related]

  • 30. Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, double-blind, placebo-controlled phase 3 trial.
    Cadot P, Hensel P, Bensignor E, Hadjaje C, Marignac G, Beco L, Fontaine J, Jamet JF, Georgescu G, Campbell K, Cannon A, Osborn SC, Messinger L, Gogny-Goubert M, Dubreuil P, Moussy A, Hermine O.
    Vet Dermatol; 2011 Dec 01; 22(6):554-64. PubMed ID: 21668810
    [Abstract] [Full Text] [Related]

  • 31. The use of recombinant omega interferon therapy in canine atopic dermatitis: a double-blind controlled study.
    Carlotti DN, Boulet M, Ducret J, Machicote G, Jasmin P, Rème CA, Albouy M.
    Vet Dermatol; 2009 Oct 01; 20(5-6):405-11. PubMed ID: 20178477
    [Abstract] [Full Text] [Related]

  • 32. The evaluation of Canine Atopic Dermatitis Extent and Severity Index (CADESI) test in dogs with atopic dermatitis (AD) treated with cyclosporine or prednisone.
    Taszkun I.
    Pol J Vet Sci; 2010 Oct 01; 13(4):681-8. PubMed ID: 21370747
    [Abstract] [Full Text] [Related]

  • 33. Management of canine atopic dermatitis using the plant extract PYM00217: a randomized, double-blind, placebo-controlled clinical study.
    Ferguson EA, Littlewood JD, Carlotti DN, Grover R, Nuttall T.
    Vet Dermatol; 2006 Aug 01; 17(4):236-43. PubMed ID: 16827666
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pilot evaluation of the antipruritic efficacy of a topical transient receptor potential melastatin subfamily 8 (TRPM8) agonist in dogs with atopic dermatitis and pedal pruritus.
    Tamamoto-Mochizuki C, Murphy KM, Olivry T.
    Vet Dermatol; 2018 Feb 01; 29(1):29-e14. PubMed ID: 28952176
    [Abstract] [Full Text] [Related]

  • 38. Preliminary evaluation of two bathing methods for the management of Malassezia overgrowth in dogs with atopic dermatitis.
    Esumi M, Kanda S, Shimoura H, Hsiao YH, Iyori K.
    Vet Dermatol; 2021 Jun 01; 32(3):228-e59. PubMed ID: 33844368
    [Abstract] [Full Text] [Related]

  • 39. Validation of the Canine Atopic Dermatitis Extent and Severity Index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs.
    Olivry T, Saridomichelakis M, Nuttall T, Bensignor E, Griffin CE, Hill PB, International Committe on Allergic Diseases of Animals (ICADA).
    Vet Dermatol; 2014 Apr 01; 25(2):77-85, e25. PubMed ID: 24461108
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.